Back

Cardioprotective effects of a ‘twincretin’ drug tirzepatide in heart failure following myocardial infarction

Cardiovascular Research

4 February 2025
Organised by: Logo
Read full article
ESC Journals BASIC SCIENCE

Contributors

Rui Shang
Rui Shang

Author

Brian Rodrigues
Brian Rodrigues

Author

You may be interested in
thumbnail
Congress Presentation
Cardiovascular outcomes across GLP-1/GIP agonists in a large, diverse real-world cohort: the INCRETIN-CV study
29 August 2026
thumbnail
Congress Session
Advances in medical therapy in heart failure
20 May 2025
thumbnail
Congress Presentation
Glucagon like peptide-1 receptor agonists and their combination with sodium-glucose cotransporter-2 inhibitors improve myocardial deformation and work index in type-2 diabetes after 12-month treatment
28 August 2020
thumbnail
Congress Presentation
GLP-1-ra and heart failure-related outcomes in patients with and without a history of heart failure: a systematic review and meta-analysis.
23 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources